Objectives. Salubrious effects of the green coffee bean are purportedly secondary to high concentrations of chlorogenic acid. Chlorogenic acid has a molecular structure similar to bioflavonoids that activate transepithelial Cltransport in sinonasal epithelia. In contrast to flavonoids, the drug is freely soluble in water. The objective of this study is to evaluate the Clsecretory capability of chlorogenic acid and its potential as a therapeutic activator of mucus clearance in sinus disease.
Introduction
Chronic rhinosinusitis (CRS) causes significant morbidity and detriment to quality of life for afflicted patients. In the disease cystic fibrosis (CF), CRS is virtually universal. CF is caused by defects in the CF transmembrane conductance regulator (CFTR), a cyclic adenosine monophosphate (cAMP)-regulated anion transporter present on the apical surface of epithelial cells in multiple tissues, including the sinonasal cavities. 1 Due to the absence of functional CFTR, airway surface liquid (ASL) depletion results, 2 contributing to delayed mucociliary clearance (MCC), bacterial colonization, and severe chronic sinus infections. 1 Non-CF patients with CRS have diminished MCC as well, which can be restored once adequate treatment to reestablish healthy mucosa has been provided. 3 Recently, a number of laboratories have shown that acquired CFTR dysfunction may cause delayed MCC even in the absence of congenital CFTR mutations and may be a contributing factor in CRS and other disease of MCC such as chronic obstructive pulmonary disease (COPD). [4] [5] [6] [7] [8] [9] [10] [11] [12] Reduced CFTR function in the nose has also been associated with chronic bronchitis, 13 suggesting that CFTR could represent a potential therapeutic target in CRS as well. [14] [15] [16] Recently, there has been increased interest in bioflavonoids and their derivatives as potential therapeutic activators of CFTR. 17, 18 Previous findings from our laboratory have demonstrated several flavonoids that enhance Clsecretion in human sinonasal epithelial cells (HSNE). [19] [20] [21] [22] One naturally derived molecule that has a similar molecular structure to flavonoids is chlorogenic acid (3-caffeoylquinic acid). The widely sought benefits of the green coffee bean are thought to be derived from high concentrations of chlorogenic acid. Salutary effects have been described for a variety of conditions, including, diabetes, weight loss, and cancer. 23 Whether chlorogenic acid might interact with the CFTR channel in a similar fashion to some flavonoids has not been previously investigated. Furthermore, the water solubility of chlorogenic acid provides a distinct advantage over flavonoids for in vivo drug delivery that would target acquired defects in CFTR-mediated Clsecretion. Given the limited treatment options for sinus disease, translating a new class of drugs aimed at restoring the airway's primary innate defense against disease (mucociliary transport) represents an exciting therapeutic approach. The objective of this study is to evaluate the Clsecretory capability of chlorogenic acid and investigate its potential as a therapeutic activator of mucus clearance in sinus disease.
Methods

University of Alabama at Birmingham Institutional Animal
Care and Use Committee and Institutional Review Board approval were obtained prior to initiation of the study. Written informed consent was obtained from each participant on a document approved by the Institutional Review Board.
Tissue Culture
Normal sinonasal mucosa was obtained intraoperatively from 5 patients undergoing endoscopic surgery for pituitary tumors, benign sinonasal tumors, or cerebrospinal fluid leak repair and 2 cystic fibrosis patients with the F508del/F508del genotype for the establishment of primary cell cultures. Primary sinonasal epithelial cells from humans and nasal septal epithelial cells from CFTR 1/1 and CFTR -/mice were cultured at an air-liquid interface according to previously established protocols. 11, 12, [24] [25] [26] [27] [28] All murine nasal septal epithelial (MNSE) cells were obtained from congenic C57/BL6 wild type and CFTR -/mice. Primary nasal epithelial cells were prepared and cultured on collagen-coated Costar 6.5 mm-diameter permeable filter supports (Corning, Lowell, Massachusetts, USA) submerged in culture media.
Electrophysiology
Short circuit current (I SC ) measurements. Transwell inserts (Costar) containing primary monolayers were configured in Ussing chambers (VCC 600; Physiologic Instruments Inc, San Diego, California, USA) in order to investigate pharmacologic manipulation of vectorial ion transport. Cell monolayers were continuously analyzed under short circuit conditions following fluid resistance compensation using automatic voltage clamps. Bath solutions for the transwell filters were warmed to 37°C, and each solution continuously gas lifted with 95%O 2 -5%CO 2 . Serosal bath solutions contained (in mM): 120 NaCl, 25 NaHCO 3 , 3.3 KH 2 PO 4 , 0.8 K 2 HPO 4 , 1.2 MgCl 2 , 1.2 CaCl 2 , and 10 glucose that provide a pH of 7.4 under conditions studied here. The solution was adequately buffered to minimize pH change with addition of chlorogenic acid and all experiments performed with a low Clgradient. Drugs included amiloride (100 mM) to block sodium transport, chlorogenic acid (1.5 mM), and CFTR(inh)172 (10 mM) to inhibit CFTRmediated I SC . Forskolin (20 mM) was added after chlorogenic acid to maximally activate CFTR via cAMP/protein kinase A (PKA)-mediated pathways. Corresponding water (vehicle) control solutions for chlorogenic acid were studied in parallel. The I SC was assessed at 1 current measurement per second. By convention, a positive deflection in I SC was defined as the net movement of anions in the serosal to mucosal direction. A minimum of 5 wells were tested per condition.
CFTR R-Domain Phosphorylation and cAMP Levels
To evaluate whether chlorogenic acid stimulates CFTR through PKA-dependent phosphorylation of the CFTR regulatory domain (R-D), an ELISA-based detection kit (Cayman Chemicals, Ann Arbor, Michigan, USA) was used to measure stimulation of cellular cAMP by chlorogenic acid in MNSE cultures, as previously described. 18 Direct evaluation of R-D phosphorylation was accomplished using polyclonal NIH-3T3 cells expressing a hemagluttinin (HA)tagged R-domain. We used the R-domain construct because the large size and glycosylation-sensitive electrophoresis pattern of native CFTR negatively affect the interpretation of mobility shift experiments. Cells were treated with chlorogenic acid (1.5 mM) for 15 minutes and compared to forskolin (20 mM) as a positive control and water as negative control. Following lysis, equal amounts (50 mg) of total cell lysate were electrophoresed through a 12% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) and immunoblotted with antibody to the HA tag (Covance, Cumberland, Virginia, USA). Phosphorylation of the R-domain was visualized as a 2-4 kD shift in migration, as previously described. 18 
Gene Expression
Total RNA was isolated with the RNeasy mini kit (Qiagen) according to manufacturer instructions. To prevent DNA contamination, samples were pretreated with RNase-free DNase (Qiagen, Venlo, The Netherlands) and column purified. The 1-step Applied Biosystems polymerase chain reaction (PCR) protocol was used to quantify CFTR transcripts with the ABI Prism 7500 sequence detection system and 6 serial dilutions of RNA isolates (Applied Biosystems, Foster City, California, USA). TaqMan OneStep PCR Master Mix Reagents Kit (ABI) was used for reverse transcription and PCR. Primers for murine CFTR, human CFTR, and 18S rRNA were purchased from Assays on Demand (ABI), with assay ID for murine CFTR, Mm00445197_m1, and human CFTR, Hs00357011_m1. The thermocycler conditions were as follows: stage 1: 48°C for 30 minutes; stage 2: 95°C for 10 minutes; stage 3: 95°C for 15 seconds; stage 4: 60°C for 1 minute; 40 cycles. All CFTR values were normalized to 18S rRNA (from the same sample) according to the Applied Biosystems relative quantification method. Experiments were performed in triplicate.
Statistical Analysis
Statistical analyses were conducted using Excel 2010 and GraphPad Prism 6.0 software (La Jolla, California, USA) with significance set at P \ .05. Statistical evaluation utilized unpaired Student t tests for Ussing chamber data and analysis of variance followed by Tukey-Kramer multiple comparison test if necessary for cAMP assay and RT-PCR. Data are expressed 6 standard error of the mean.
Results
Chlorogenic Acid Is a Robust Cl -Secretagogue
The optimal concentration of chlorogenic acid for stimulating transepithelial Clsecretion (change in short-circuit current [DI SC in mA/cm 2 ]) in MNSE and HSNE was 1.5 mM as determined by dose-response experiments (data not shown). Chlorogenic acid stimulated transepithelial Cltransport in MNSE (13.1 6 0.9 vs 0.1 6 0.1, control; P \ .05) but had a slower onset to peak effect (15 to 30 min after application) than usual CFTR activators like forskolin (Figure 1) . Interestingly, maximal activation of CFTR with forskolin was significantly greater in cultures incubated with chlorogenic acid than water controls (chlorogenic acid 1 forskolin, 20.5 6 2.6 vs control1forskolin, 14.4 6 2.3; P \ .05). Addition of the CFTR blocker INH-172 reduced I SC in a similar fashion (-18.5 6 0.8 vs 216.1 6 1.5, control; P \ .05). Because CFTR -/-MNSE cultures had no response to the drug, stimulation of transepithelial anion secretion is dependent on intact CFTR-mediated pathways.
Chlorogenic Acid Stimulates CFTR-Mediated Transepithelial Cl -Transport in Human Sinonasal Epithelia
Chlorogenic acid significantly increased DI SC in HSNE cultures (34.1 6 0.3 vs 0.0 6 0.2, control; P \ .05), establishing that the agent is a strong Cl 2 secretagogue in human sinus and nasal epithelium ( Figure 2 ). However, a much larger percentage (.80%) of total DI SC was stimulated when compared to MNSE, indicating the drug may have enhanced activity in human epithelia. The marked increase in total DI SC with chlorogenic acid 1 forskolin indicates anion secretion was present in quantities above what would be expected with maximally activated CFTR in control 1 forskolin-treated cultures (40.8 6 3.2 vs 24.5 6 0.8; P \ .05). HSNE cultures derived from patients who lack functional CFTR (F508del/dF508del) exhibited no stimulation of Clsecretion following treatment with the drug. Chlorogenic acid-stimulated DI SC is also greater than water control when CFTR is maximally activated with forskolin in both sets of cultures (*P \ .05). INH-172 also significantly inhibited DI SC in chlorogenic acid treated monolayers (*P \.05). (C) CFTR 2/2 cultures tested with the drug reveal its effects are dependent on CFTR-mediated pathways.
Stimulated CFTR-Dependent Anion Transport Is Independent of cAMP Signaling and R-D Phosphorylation
The PKA-dependent phosphorylation of the CFTR R-D is a critical step in channel activation, but flavonoid compounds (eg, genistein 29 ) have been shown to act through potentiation of CFTR channel opening rather than activating cAMPmediated cell-signaling pathways. To examine whether chlorogenic acid might activate CFTR via these PKA-dependent pathways, cAMP levels and R-D phosphorylation were assessed. While the cAMP agonist forskolin had markedly increased cAMP levels (P \ .001) and phosphorylationdependent mobility shift of recombinant CFTR R-D, chlorogenic acid had no detectable effect in either assay (Figure 3 ).
Delayed Onset of Activity Is Not Secondary to Increased mRNA Transcription
To rule out the possibility that the drug's delayed activity could be attributable to increased mRNA transcription, quantitative RT-PCR for CFTR was performed. CFTR mRNA levels remained unchanged following incubation with the drug (Figure 4) . 
Discussion
Bioflavonoids have garnered significant attention over the past decade due to a variety of health benefits and favorable biological activities. Pharmacologic activation of the CFTR channel to potentiate mucociliary clearance in CF patients is an active area of research, with previous findings from our laboratory demonstrating several flavonoid compounds that increase ion transport via the CFTR channel. [30] [31] [32] [33] However, bioflavonoids are insoluble in water, and thus other solvents such as dimethyl sulfoxide (DMSO) are required to administer the agents as topical therapeutics. Known side effects of DMSO include headaches, burning and itching, and skin contact allergic reactions, and the solvent is thought to augment the effects of steroids, blood thinners, cardiac medicines, sedatives, and other drugs. 34 Thus, water-soluble potentiators of CFTR that have similar methods of action have valuable potential for both oral and topical delivery.
In the current study, we evaluated the ability of chlorogenic acid to activate CFTR-dependent Cltransport in primary cell culture models of sinonasal epithelium. Chlorogenic acids have been found to attenuate oxidative stress, 35 inhibit enzymes associated with lipid metabolism, 36 and ameliorate the tumor-promoting activity of phorbol esters. 37 Despite similarities to flavonoid structure, no previous studies have investigated the effects of the drug on transepithelial ion transport. Importantly, chlorogenic acid has been shown to modulate ion channels in other cells, specifically, voltage gated potassium channels in sensory neurons. 38 Our findings indicate chlorogenic acid (1.5 mM) robustly stimulates CFTR in upper airway cell monolayers, albeit with a longer duration to peak effect than flavonoids and other drugs. Inhibition with INH-172 in CFTR 1/1 epithelia and lack of transepithelial Clsecretion in CFTR -/-MNSE and dF508/dF508 HSNE monolayers suggest the action of chlorogenic acid is dependent on the presence of functional CFTR. However, stimulation of vectorial anion transport was increased over what was seen with maximally activating forskolin alone. Thus, the drug may stimulate anion transport by other means as well (eg, basolateral membrane K 1 channel activation) to increase the driving force through CFTR-mediated pathways.
Further exploration of the drug's mechanism of action was performed to determine whether increased CFTRmediated Clsecretion could be explained by triggering cellular cAMP signaling and subsequent activation of the CFTR R-D. After exposure to chlorogenic acid, there was no elevation of cellular cAMP or phosphorylation of the R-domain according to gel shift assay. Subsequent investigations regarding the agent's ability to potentiate CFTR channel opening were not successful using excised insideout patch clamp techniques because of the drug's delayed effect and inability to hold a patch for the duration of the experiments (data not shown). There was also no increase in gene expression with exposure to chlorogenic acid. Additional tests will be required to determine the precise mechanism of action underlying robust stimulation of Clsecretion conferred by this agent.
Conclusion
In summary, chlorogenic acid activates CFTR-mediated Clsecretion in murine and human sinonasal epithelium. Using a water-soluble activator of transepithelial Cltransport to enhance MCC could be potentially beneficial in individuals with CRS. Further in vivo evaluation in human subjects is planned.
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